Ñèíîíèìû. Èíîçèí - Inosin; Èíîçèå-Ô - Inosie-F (ßï.). Ëåêàðñòâåííûå ôîðìû. Ðèáîêñèí - ñèíòåòè÷åñêèé ïðåïàðàò. Âûïóñêàåòñÿ â òàáëåòêàõ ïî 0,2 ã, ïîêðûòûõ îáîëî÷êîé æåëòîãî öâåòà, â óïàêîâêå ïî 50 øòóê è â óïàêîâêå ïî 10 øòóê, è â àìïóëàõ ïî 10 ìë 2% ðàñòâîðà.
Ëå÷åáíûå ñâîéñòâà. Ðèáîêñèí ÿâëÿåòñÿ àíàáîëè÷åñêèì ñðåäñòâîì, óâåëè÷èâàåò ñèíòåç áåëêà â òêàíÿõ. Ïðåïàðàò ñòèìóëèðóåò îáìåí âåùåñòâ â êëåòêàõ, ïîâûøàåò óñòîé÷èâîñòü êëåòîê è òêàíåé ê êèñëîðîäíîé íåäîñòàòî÷íîñòè, ïîëîæèòåëüíî âëèÿåò íà îáìåííûå ïðîöåññû è ïîâûøàåò ýíåðãåòè÷åñêèå çàïàñû â ñåðäå÷íîé ìûøöå. Óëó÷øàåò êðîâîîáðàùåíèå â ìèîêàðäå.
Ïîêàçàíèÿ ê ïðèìåíåíèþ.
Ðèáîêñèí ïðèìåíÿåòñÿ ïðè èøåìè÷åñêîé áîëåçíè ñåðäöà, íàðóøåíèÿõ îáìåíà âåùåñòâ â ñåðäå÷íîé ìûøöå (ìèîêàðäèîäèñòðîôèÿ, ìèîêàðäèîïàòèÿ) ñ îñëàáëåíèåì ðàáîòû ñåðäöà, à òàêæå ïðè àðèòìèÿõ, ñâÿçàííûõ ñ ïðèìåíåíèåì ñåðäå÷íûõ ãëèêîçèäîâ. Êðîìå ýòîãî, ðèáîêñèí ïðèìåíÿåòñÿ äëÿ ëå÷åíèÿ çàáîëåâàíèé ïå÷åíè (ãåïàòèòû, öèððîç) â ñòàäèè ñïîêîéíîãî òå÷åíèÿ. Èñïîëüçóåòñÿ ïðè ãëàóêîìå, èñòîùåíèè ïîñëå äëèòåëüíûõ çàáîëåâàíèé è îïåðàöèé.
McNaughton L, Dalton B, Tarr J.
Sports Science Dept., Kingston University, Kingston upon Thames, Surrey, England.
The two basic aims of this study were to add to the limited literature concerning Inosine as an ergogenic aid, and to determine the effects of Inosine supplementation over a period of 5 and 10 days, at a dosage of 10,000 mg.d-1 on measures associated with aerobic and anaerobic performance. Seven trained, volunteer male subjects (body mass = 63.0 8.7 kg, VO2max = 67.9 3.3 ml.kg-1.min-1) participated in this study. The subjects completed three test sessions, each comprising three tests (5 x 6-s sprint, 30-s sprint, and 20-min time trial). Supplementation was carried out in a random, double-blind manner, and the test sessions were undertaken prior to (Baseline, B), on Day 6, and on Day 11. Blood was sampled prior to supplementation as well as on Days 6 and 11 and was analyzed for uric acid and 2,3 DPG. An analysis of the data indicated no performance benefit of supplementation and no improvement in 2,3 DPG concentration. Uric acid concentration increased significantly after both Days 6 and 11 (p < 0.03 and p < 0.004, respectively). It is concluded that Inosine has no ergogenic effects but may cause possible health problems if taken over long periods of time.